The Gross Margin of Karo Pharma AB (KARO.ST) is 57.62%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2021-12-31 | 57.62% |
| 2020-12-31 | 55.34% |
| 2019-12-31 | 51.76% |
| 2018-12-31 | 58.12% |
| 2017-12-31 | 51.99% |
| 2016-12-31 | 42.83% |
| 2015-12-31 | 41.39% |
| 2014-12-31 | - |